| 【行业研究】中国医药 - 回调带来抄底机会 |
| 【公司研究】中国生物制药 (1177 HK) - PDE3/4抑制剂 II期临床数据亮眼，市场潜力巨大 |
| 【Company Research】Alibaba (BABA US) - Quick commerce investment peaked out; accelerating AI adoption |
| 【Sector Research】Capital Goods - HDT sales +82% YoY in Sep |
| 【Sector Research】Materials - Tight uranium supply continues to support a multi-year upcycle; Positive on CGN Mining |
| 【Company Research】CGN Mining (1164 HK) - Further upside driven by higher uranium price |
| 【Company Research】Alibaba (BABA US) - Cloud and e-commerce development both in good shape; reiterate BUY |
| 【公司研究】药明康德 (603259 CH) - 投资者日：TIDES势头延续，早期研发初现回暖 |
| 【行业研究】中国医药 - 预期中美创新合作将持续，国内创新研发需求回暖 |
| 【Company Research】Xiaomi (1810 HK) - Product launch takeaways: Xiaomi 17’s competitive pricing; IoT upgrade and EV customization services |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
